You face constant pressure to manage your clients’ pharmacy benefits costs. And so, when pharmacy benefits management (PBM) models offer fresh savings promises, they easily capture attention. Simple narratives, bold promises, and a well-rehearsed finalist presentation can make almost any alternative look like the smarter move.
But what many clients actually experience when they switch PBMs is another matter entirely. A growing number of employers have discovered the hard way that a PBM change that looked right on paper actually left them underwhelmed and disappointed..
In some cases, that disappointment becomes clear enough that employers reverse course. RxBenefits has seen a notable increase in returning clients across sizes, industry, and location in recent years – signaling that the gap between a compelling sales story and real-world execution is larger than many buyers expect.
The lesson is not that benefits advisors should stop evaluating the options they bring to clients. It’s that this evaluation has to go deeper.
The market has gotten more complex – and more crowde
It makes sense to review the market and seek better value. Today’s buyers are fielding pitches from disruptor PBMs promising leaner structures and better transparency, integrated carriers bundling pharmacy into a broader benefits package, and direct-to-PBM arrangements that cut out the intermediary entirely.
Each model has its own story, and some of those stories are genuinely compelling. Disruptors frame their offer around transparency and visibility into plan economics. Integrated carriers emphasize coordination and administrative ease. Direct arrangements appeal to buyers who want fewer moving parts.
What the story rarely covers is what happens after the contract is signed. Organizations that have reconsidered their pharmacy strategy after a switch describe a consistent set of challenges regardless of the model they tried. Implementation timelines that did not hold. Service structures that looked strong in the presentation but were thin on the ground. Financial performance that fell short of what was promised in the sales cycle. And in too many cases, a vendor that had won business faster than it could build the infrastructure to support it.
There is a pattern of buyers not pressure testing the right things before they commit, regardless of the chosen PBM model.
A compelling presentation is not a proven operating model
There is a meaningful difference between a vendor that tells a great story and a vendor that executes reliably over time. The challenges that surface most often in organizations that switched and regretted it tend to cluster around a few recurring themes:
- Implementation hurdles: A poor implementation does not just delay go-live. It disrupts member access to medications, creates internal credibility problems, and sets the tone for the entire relationship.
- Unmet financial expectations: Pricing may look attractive up front, but long-term results are what matter. When operational support is thin or clinical oversight is weak, the financial promises made during the sales cycle rarely hold up over time.
- Service gaps after go-live: Managing a complex pharmacy plan requires deep structural support. When a vendor lacks operating depth, the signs show up quickly — slow response times, service breakdowns, and ongoing administrative headaches that consume your team’s time.
- Specialty and clinical blind spots: A small percentage of claims drives a disproportionate share of total pharmacy cost. Managing that spend requires clinical expertise, proactive intervention, and a structured specialty program. When those capabilities are underdeveloped, the financial exposure can be significant and fast-moving.
Larger and more complex accounts feel these gaps acutely. When an employer has thousands of members, intricate plan design requirements, or a high-cost specialty population, the stakes of a poor implementation or a weak service model are amplified.
Why the homework has to come before the switch
Every employer has the right to evaluate their options. The market is competitive, and alternatives should be considered seriously. But the benefits advisors and employers who navigate these decisions most successfully are the ones who pressure-test the claims before they sign on the dotted line.
Before committing to a vendor change, separate the sales story from the operational reality by asking these five questions:
1. Are your financial commitments in writing – and guaranteed? Do not accept verbal assurances. Ask for written guarantees and a clear remediation plan if the vendor falls short. If they hesitate, that tells you something (or maybe “all you need to know”).
2. How do you manage complex clinical needs and specialty medications? Ask for concrete examples — not generalities — of how their clinical team intervenes on high-cost claims and supports members with serious conditions. The answer should be specific and detailed.
3. Can you prove implementation readiness? Request documented examples of successful onboarding for groups with your size and complexity. Ask directly: what went wrong in past implementations, and how did you resolve issues that arose?
4. What evidence shows your model can scale? A vendor growing quickly must demonstrate that their infrastructure can grow with them. You need confidence that the service team handling your account today will not be stretched thin by new business volume six months from now.
5. What does the service structure look like after go-live? Clarify exactly who owns your day-to-day account relationship, how issues are escalated, and what accountability looks like in year two and year three. The vendors who perform well after go-live are the ones who plan for it before the contract is signed.
Experience, dependability, and proven execution
A vendor’s track record is not just a marketing credential. It reflects the institutional knowledge, operational infrastructure, and pattern recognition that come from managing pharmacy plans through changing market conditions, regulatory shifts, and evolving clinical landscapes over many years.
The clients who return to RxBenefits come back because they experienced the difference that operating depth makes.
That’s because our thirty years in the market means something. It means detailed processes that have been refined through thousands of implementations. It means service teams that know what’s important to clients and their members and deliver meaningful, sustainable results. – It means human-led clinical programs built on evidence and outcomes, not assumptions. And it means a record of accountability that goes beyond what any finalist presentation can convey.
The pharmacy benefits market will keep evolving. New or updated models will continue to compete for business, and some will bring genuine value. The goal is not to dismiss innovation – it is to evaluate it honestly. The strongest long-term choice is the partner that makes a clear promise and has the depth, discipline, and track record to keep it. Look beyond the headlines, ask the hard questions, and choose a partner built to execute long after the ink is dry.
